Getting Your Pathology Slides and Blocks Sent Out for Review

How do I get my pathology slides sent for review?

To have your pathology reviewed by another doctor, you request the original glass slides — and often the paraffin block — from the laboratory that processed your biopsy, and arrange for them to be sent to the pathologist doing the review. You have a right to this: patients are entitled to copies of their records and to their pathology materials, and seeking a second opinion is a normal, expected part of care 1Ref 1American Cancer Society (2024).Seeking a Second Opinion.That patients are entitled to copies of their records and to their pathology materials, and that seeking a second opinion is a normal, expected part of cancer care.. The materials themselves are loaned and returned, because the glass is irreplaceable.

The request usually starts as a signed release to the pathology department or medical-records office at the hospital or lab where the biopsy was read. Often the institution doing the second opinion will help — many will send you a request form and coordinate the transfer directly with the original lab. Either way, the reviewing pathologist needs the actual stained glass, because a diagnosis is made by looking at cells, not by reading someone else's description of them.

A pathology second opinion needs the physical slides and often the tissue block — the written report alone is not enough for an independent read.

Slides, blocks, and the report — what actually gets sent

Three different things travel in a pathology review, and they are not interchangeable. The glass slide is a paper-thin slice of your tissue, stained and mounted on glass, which is what a pathologist actually examines under the microscope. The paraffin block is the rest of your tissue sample, preserved in a small wax cube; new slides and additional special stains can be cut from it if the reviewer needs them. The pathology report is the written interpretation — useful context, but not something a second pathologist can re-examine.

For most reviews, the original stained slides are the core of what is sent. When the diagnosis is difficult or the reviewer wants extra tests — special stains, molecular studies — the block matters, because those tests consume tissue that only the block contains. Sometimes the original lab prefers to keep the block and cut fresh slides, called recuts, to send instead, which is common and generally fine.

You can obtain your pathology report separately as a copy, and it is worth having, but the report is a starting point for the review, not a substitute for the glass. When you ask the pathology department for the slides and the block by name, they know exactly what you mean and you avoid receiving only the report.

Why the physical slides matter, not just the report

The reason a reviewer needs the actual glass is that pathology is interpretation, and skilled interpreters do not always agree — especially at the borderline. When practicing pathologists read breast biopsies, agreement with an expert reference was high for clear invasive cancer but only about 48 percent for atypia, with the rest split between over-calling and under-calling it 2Ref 2Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson ANA, Nelson HD, Pepe MS, Allison KH, Schnitt SJ, O'Malley FP, Weaver DL (2015).Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens.That pathologist interpretation of borderline breast lesions varies substantially — about 48% concordance for atypia and 84% for DCIS against an expert reference — motivating expert re-review of the actual slides.. A report that says atypia is a conclusion a second expert may read differently from the same slide.

Rare tumors raise the stakes further. Among soft-tissue sarcoma cases, diagnostic concordance ranged from under 30 percent at general clinics to around 70 percent at an expert center, and expert review improved or confirmed the correct primary diagnosis in roughly three-quarters of cases 3Ref 3Lehnhardt M, Daigeler A, Hauser J, Puls A, Soimaru C, Kuhnen C, Steinau HU (2008).The value of expert second opinion in diagnosis of soft tissue sarcomas.That for rare tumors like soft-tissue sarcoma, initial diagnostic concordance is low (28.3% at private clinics vs 70.5% at the expert center) and expert second review improved or confirmed the correct diagnosis in 73.1% of cases.. These are exactly the diagnoses where a fresh read of the glass changes the plan, and where a cancer second opinion often hinges on the pathology rather than the clinical exam.

Even across ordinary surgical pathology, re-review of outside slides catches major, care-changing errors — about 1.4 percent of more than six thousand cases in one landmark study 4Ref 4Kronz JD, Westra WH, Epstein JI (1999).Mandatory second opinion surgical pathology at a large referral hospital.That re-review of outside surgical-pathology slides catches major, care-changing diagnostic errors at a low but consequential rate (86 of 6,171 cases, about 1.4%).. That rate is low, but it is not zero, and when your slide is the one that changes, the physical review is the only thing that would have caught it. None of this can be done from the report alone.

Who reviews outside slides, and finding the right expertise

The right reviewer is usually a subspecialty pathologist — someone who reads your specific kind of tissue all day, whether that is a hematopathologist for a lymphoma, a dermatopathologist for a skin lesion, or a sarcoma expert for soft tissue. Subspecialty focus is where the value of a slide re-read concentrates, because expertise in pathology is narrow and deep. Your treating oncologist or surgeon can often name the right kind of expert, and many academic pathology departments run formal second-opinion consultation services that accept outside slides and blocks for subspecialty review 5Ref 5Johns Hopkins Pathology (2025).Get a Second Opinion — Johns Hopkins Pathology.That academic pathology departments run formal second-opinion consultation services in which patients or providers can submit slides and reports for expert subspecialty re-review (cited only for the existence of such programs, not for any specific submission process)..

Rather than chasing a particular famous name, focus on matching the reviewer to the specimen. A general second look adds less than a targeted one from someone whose daily work is your tumor type. If you are unsure who that is, ask the reviewing institution's pathology department directly — they can tell you whether they have the relevant subspecialist on staff.

This is also where a pathology slide re-read differs from a clinical second opinion. You are not asking another doctor whether the treatment is right; you are asking another pathologist whether the diagnosis on the glass is right. Getting that specialist match correct is most of the value.

How to make the request, step by step

The request is a short, concrete process, and knowing the order keeps it from stalling. The core steps are usually the same wherever your biopsy was read:

• Choose the reviewer first. Decide which pathologist or institution will do the review, because the release usually names where the materials should be sent.
• Submit a written release to the pathology department or medical-records office at the original lab, authorizing them to send your slides and block. Ask specifically for both.
• Include your identifiers — full name, date of birth, the accession or case number printed on your pathology report, and the date of the biopsy — so the lab can locate the exact specimen.
• Ask how they send it and whether they keep the block. Some send original slides and the block; some send recuts. Either is workable; you just want to know which.
• Confirm the destination address and attention line with the reviewing pathology department, since specimens go to the lab, not to a clinic front desk.

Many second-opinion programs streamline this by sending you a single request form that they then handle with the original lab. If yours does, use it — it removes several of the handoffs where materials most often go astray.

Shipping, tracking, and getting your materials back

Because the glass is irreplaceable, how it travels matters. Pathology materials are shipped in protective slide holders by tracked, insured courier, and the labs on both ends log them in and out. You are entitled to have the original slides returned to the issuing lab after the review, and reputable programs return them as a matter of routine — the loan is temporary, not a surrender of your tissue.

A few practical habits prevent the most common problems. Keep the tracking number and the case identifiers yourself, so you can follow the shipment and prove what was sent if anything goes missing. Confirm with the reviewing lab that the materials actually arrived, rather than assuming; the handoff between two institutions is where slides most often stall. And if the block was sent, ask that it too be returned or accounted for, since it holds tissue that cannot be regrown.

If a lab ever tells you it cannot locate or has discarded your materials, ask for that in writing and escalate to the pathology department's medical director. This is uncommon, but the paper trail is your protection, and the materials belong to your care.

What it costs and whether insurance helps

Expect two possible charges, and they are separate from each other: a handling or preparation fee from the original lab for retrieving and shipping your materials, and the professional fee for the reviewing pathologist's interpretation. These vary by institution, and it is reasonable to ask each side for the cost before you commit, so a surprise pathology bill does not arrive weeks later.

Whether insurance covers the interpretation depends on your plan. If you have a Medicare Advantage plan, the review may need to be done with an in-network pathologist or require prior authorization, since these plans can use provider networks and pre-authorization rules while still covering at least what Original Medicare does 6Ref 6Centers for Medicare & Medicaid Services (2024).Medicare Advantage & other health plans.That Medicare Advantage plans may use provider networks and prior authorization while covering at least the same benefits as Original Medicare — so a pathology review may need an in-network reviewer or pre-authorization.. Calling your plan before the slides move is the simplest way to avoid an out-of-network reading you did not expect.

The lab retrieval fee is often modest relative to the stakes of the diagnosis, but it is worth confirming, especially when the review is not going through a program that bundles the costs. Getting the numbers in advance — from the original lab, the reviewing lab, and your insurer — is the reliable way to head off an out-of-network pathology billing surprise.

Timing, and how to avoid a dangerous delay

Plan for the transfer to take longer than a clinic visit — typically several days to a couple of weeks — because it involves two labs, a physical shipment, and paperwork on both ends. The slowest step is almost always the release and retrieval at the original lab, not the review itself. Requesting the slides early, before your consultation is even scheduled, keeps the materials from becoming the bottleneck.

If the diagnosis is time-sensitive, say so to both labs and ask them to expedite; most will. It also helps to gather the other records for a second opinion at the same time, so that imaging on a disc, reports, and slides all arrive together rather than in a slow trickle. A single, complete package lets the reviewer read everything at once instead of waiting on stragglers.

Above all, do not let the logistics of moving glass delay a genuinely urgent treatment decision. If your care team needs to begin treatment before a slide review can be completed, that is a conversation to have openly with them — the review can sometimes proceed in parallel. The goal is a confirmed diagnosis without a dangerous wait, and telling both teams exactly what you need is how you get it.